NGS, RNA-Seq, TIL, and PTEN analyses in prostate cancer specimens from patients enrolled in the study of the Akt inhibitor ipatasertib (Ipat) combined with abiraterone acetate (AA).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Liangxuan Zhang, Hartmut Koeppen, Daniel J. Maslyar, Dimitri Fillos, Na Xu, Wai Y. Chan, Albert Font Pous, Viorel Jinga, Christophe Massard, Sergio Bracarda, George Daniel Radavoi, Ugo De Giorgi, Jose Angel Arranz Arija, Ruth Riisnaes, Daniel Nava Rodrigues, Johann S. De Bono, Steven Gendreau
Institutions: Genentech, Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Carol Davila University of Medicine and Pharmacy, Institut Gustave Roussy, Ospedale San Donato, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Hospital General Universitario Gregorio Marañón, Royal Marsden NHS Foundation Trust, Institute of Cancer Research
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2791669781